397
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Psychosocial and Clinical Risk Factors Associated with Substance Use in Observational Cohort of Patients with Sickle Cell Disease

, , , , & ORCID Icon

References

  • Adam, S. S., Flahiff, C. M., Kamble, S., Telen, M. J., Reed, S. D., & De Castro, L. M. (2017). Depression, quality of life, and medical resource utilization in sickle cell disease. Blood Advances, 1(23), 1983–1992. https://doi.org/10.1182/bloodadvances.2017006940
  • Anderson, K., Syrjala, K., & Cleeland, C. (Eds.). (2001). How to assess cancer pain. (2nd ed.). Guilford Press.
  • Ballas, S. (2017). The use of cannabis by patients with sickle cell disease increased the frequency of hospitalization due to vaso-occlusive crises. Cannabis and Cannabinoid Research, 2(1), 197–201. https://doi.org/10.1089/can.2017.0011
  • Banerjea, R., Sambamoorthi, U., Smelson, D., & Pogach, L. M. (2007). Chronic illness with complexities: Mental illness and substance use among Veteran clinic users with diabetes. The American Journal of Drug and Alcohol Abuse, 33(6), 807–821. https://doi.org/10.1080/00952990701653701
  • Bediako, S., Lanzkron, S., Diener-West, M., Onojobi, G., Beach, M., & Haywood, C. (2016). The measure of sickle cell stigma: Initial findings from the improving patient outcomes through respect and trust study. Journal of Health Psychology, 21(5), 808–820. https://doi.org/10.1177/1359105314539530
  • Brown, S., Weisberg, D., Balf-Soran, G., & Sledge, W. (2015). Sickle cell disease patients with and without extremely high hospital use: Pain, opioids, and coping. Journal of Pain and Symptom Management, 49(3), 539–547. https://doi.org/10.1016/j.jpainsymman.2014.06.007
  • Buckner, J., Keough, M., & Schmidt, N. (2007). Problematic alcohol and cannabis use among young adults: The roles of depression and discomfort and distress tolerance. Addictive Behaviors, 32(9), 1957–1963. https://doi.org/10.1016/j.addbeh.2006.12.019
  • Bulgin, D., Tanabe., & Jenerette, C. (2018). Stigma of sickle cell disease: A systematic review. Issues in Mental Health Nursing, 39(8), 675–686. https://doi.org/10.1080/01612840.2018.1443530
  • Citero, V. A., Levenson, J. L., McClish, D. K., Bovbjerg, V. E., Cole, P. L., Dahman, B. A., Penberthy, L. T., Aisiku, I. P., Roseff, S. D., & Smith, W. R. (2007). The role of catastrophizing in sickle cell disease--the PiSCES project. Pain, 133, 39–46. https://doi.org/10.1016/j.pain.2007.02.008
  • Clark, R. E., Samnaliev, M., & McGovern, M. P. (2009). Impact of substance disorders on medical expenditures for medicaid beneficiaries with behavioral health disorders. Psychiatric Services (Washington, D.C.), 60(1), 35–42. https://doi.org/10.1176/ps.2009.60.1.35
  • Cohen, M., Quintner, J., Buchanan, D., Nielsen, M., & Guy, L. (2011). Stigmatization of patients with chronic pain: The extinction of empathy. Pain Medicine (Malden, Mass.), 12(11), 1637–1643. https://doi.org/10.1111/j.1526-4637.2011.01264.x
  • Cooper, A. E., Corrigan, P. W., & Watson, A. C. (2003). Mental illness stigma and care seeking. The Journal of Nervous and Mental Disease, 191(5), 339–341. https://doi.org/10.1097/01.NMD.0000066157.47101.22
  • Corrigan, P. W., Druss, B. G., & Perlick, D. A. (2014). The impact of mental illness stigma on seeking and participating in mental health care. Psychological Science in the Public Interest: a Journal of the American Psychological Society, 15(2), 37–70. https://doi.org/10.1177/1529100614531398
  • Davis, L., Uezato, A., Newell, J., & Frazier, E. (2008). Major depression and comorbid substance use disorders. Current Opinion in Psychiatry, 21(1), 14–28. https://doi.org/10.1097/YCO.0b013e3282f32408
  • Dorsey, C., Phillips, K. D., & Williams, C. (2001). Adult sickle cell patients' perceptions of nurses' caring behaviors. The ABNF Journal: Official Journal of the Association of Black Nursing Faculty in Higher Education, Inc, 12(5), 95–100. https://www.ncbi.nlm.nih.gov/pubmed/11760332
  • Elander, J., Lusher, J., Bevan, D., Telfer, P., & Burton, B. (2004). Understanding the causes of problematic pain management in sickle cell disease: Evidence that pseudoaddiction plays a more important role than genuine analgesic dependence. Journal of Pain and Symptom Management, 27(2), 156–169. https://doi.org/10.1016/j.jpainsymman.2003.12.001
  • Finan, P. H., Carroll, C. P., Moscou-Jackson, G., Martel, M. O., Campbell, C. M., Pressman, A., Smyth, J. M., Tremblay, J., Lanzkron, S. M., & Haythornthwaite, J. A. (2018). Daily opioid use fluctuates as a function of pain, catastrophizing, and affect in patients with sickle cell disease: An electronic daily diary analysis. The Journal of Pain, 19(1), 46–56. https://doi.org/10.1016/j.jpain.2017.08.010
  • Ford, J. D., Trestman, R. L., Steinberg, K., Tennen, H., & Allen, S. (2004). Prospective association of anxiety, depressive, and addictive disorders with high utilization of primary, specialty and emergency medical care. Social Science & Medicine (1982), 58(11), 2145–2148. https://doi.org/10.1016/j.socscimed.2003.08.017
  • Fox, K., Merrill, J. C., Chang, H. H., & Califano, J. A. Jr.(1995). Estimating the costs of substance abuse to the Medicaid hospital care program. American Journal of Public Health, 85(1), 48–54. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/7832261 https://doi.org/10.2105/ajph.85.1.48
  • Freiermuth, C. E., Haywood, C., Jr, Silva, S., Cline, D. M., Kayle, M., Sullivan, D., Thornton, V., & Tanabe, P. (2014). Attitudes towards patients with sickle cell disease in a multicenter sample of emergency department providers. Advanced Emergency Nursing Journal, 36(4), 335–347.
  • Galen, L., Henderson, M., & Coovert, M. (2001). Alcohol expectancies and motives in a substance abusing male treatment sample. Drug and Alcohol Dependence, 62(3), 205–214. https://doi.org/10.1016/S0376-8716(00)00168-X
  • Graves, J. K., Hodge, C., & Jacob, E. (2016). Depression, anxiety, and quality of life in children and adolescents with sickle cell disease. Pediatric Nursing, 42(3), 113–119.
  • Green, C. R., Anderson, K. O., Baker, T. A., Campbell, L. C., Decker, S., Fillingim, R. B., Kalauokalani, D. A., Kaloukalani, D. A., Lasch, K. E., Myers, C., Tait, R. C., Todd, K. H., & Vallerand, A. H. (2003). The unequal burden of pain: Confronting racial and ethnic disparities in pain. Pain Medicine (Malden, Mass.), 4(3), 277–294. https://www.ncbi.nlm.nih.gov/pubmed/12974827 https://doi.org/10.1046/j.1526-4637.2003.03034.x
  • Green, C. R., & Hart-Johnson, T. (2010). The impact of chronic pain on the health of black and white men. Journal of the National Medical Association, 102(4), 321–331. https://www.ncbi.nlm.nih.gov/pubmed/20437739 https://doi.org/10.1016/S0027-9684(15)30604-0
  • Hasan, S. P., Hashmi, S., Alhassen, M., Lawson, W., & Castro, O. (2003). Depression in sickle cell disease. Journal of the National Medical Association, 95(7), 533–537. https://www.ncbi.nlm.nih.gov/pubmed/12911250
  • Haywood, C., Jr., Bediako, S., Lanzkron, S., Diener-West, M., Strouse, J., Haythornthwaite, J., Onojobi, G., Beach, M. C., & for the Import Investigators. (2014). An unequal burden: Poor patient-provider communication and sickle cell disease. Patient Education and Counseling, 96(2), 159–164. https://doi.org/10.1016/j.pec.2014.05.013
  • Haywood, C., Lanzkron, S., Bediako, S., Strouse, J. J., Haythornthwaite, J., Carroll, C. P., Diener-West, M., Onojobi, G., Beach, M. C., & for the IMPORT Investigators (2014). Perceived discrimination, patient trust, and adherence to medical recommendations among persons with sickle cell disease. Journal of General Internal Medicine, 29(12), 1657–1662. https://doi.org/10.1007/s11606-014-2986-7
  • Haywood, C., Lanzkron, S., Carroll, C. P., Strouse, J. J., Bediako, S. M., Haythornthwaite, J., Onojobi, G. T., & Beach, M. C. (2013). Perceived discrimination in health care is associated with daily chronic pain in sickle cell disease. Blood, 122(21), 5577–5577. https://doi.org/10.1182/blood.V122.21.5577.5577
  • Henderson, C., Evans-Lacko, S., & Thornicroft, G. (2013). Mental illness stigma, help seeking, and public health programs. American Journal of Public Health, 103(5), 777–780. https://doi.org/10.2105/AJPH.2012.301056
  • Holloway, B. M., McGill, L. S., & Bediako, S. M. (2017). Depressive symptoms and sickle cell pain: The moderating role of internalized stigma. Stigma and Health, 2(4), 271–280. https://doi.org/10.1037/sah0000060
  • Howard, J., Anie, K., Holdcroft, A., Korn, S., & Davies, S. (2005). Cannabis use in sickle cell disease: A questionnaire study. British Journal of Haematology, 131(1), 123–128. https://doi.org/10.1111/j.1365-2141.2005.05723.x
  • Jenerette, C., Brewer, C. A., Crandell, J., & Ataga, K. I. (2012). Preliminary validity and reliability of the sickle cell disease health-related stigma scale. Issues in Mental Health Nursing, 33(6), 363–369. https://doi.org/10.3109/01612840.2012.656823
  • Jonassaint, C., Jones, V., Leong, S., & Frierson, G. (2016). A systematic review of the association betwen depression and health care utilization in children and adults with sickle cell disease. British Journal of Haematology, 174(1), 136–147. https://doi.org/10.1111/bjh.14023
  • Kalu, N., O'Neal, P., Nwokolo, C., Diaz, S., & Owoyemi, O. (2016). The use of marijuana and hydroxyurea among sickle cell patients. Blood, 128(22), 5913–5913. https://doi.org/10.1182/blood.V128.22.5913.5913
  • Kessler, R. C., Crum, R. M., Warner, L. A., Nelson, C. B., Schulenberg, J., & Anthony, J. C. (1997). Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Archives of General Psychiatry, 54(4), 313–321. https://www.ncbi.nlm.nih.gov/pubmed/9107147 https://doi.org/10.1001/archpsyc.1997.01830160031005
  • Knight-Madden, J., Lewis, N., & Hambleton, I. R. (2006). The prevalence of marijuana smoking in young adults with sickle cell disease: A longitudinal study. West Indian Medical Journal, 55(4), 224–227. https://www.ncbi.nlm.nih.gov/pubmed/17249310
  • Kulesza, M., Watkins, K. E., Ober, A. J., Osilla, K. C., & Ewing, B. (2017). Internalized stigma as an independent risk factor for substance use problems among primary care patients: Rationale and preliminary support. Drug and Alcohol Dependence, 180, 52–55. https://doi.org/10.1016/j.drugalcdep.2017.08.002
  • Labbe, E., Herbert, D., & Haynes, J. (2005). Physicians' attitude and practices in sickle cell disease pain management. Journal of Palliative Care, 21(4), 246–251. https://www.ncbi.nlm.nih.gov/pubmed/16483093 https://doi.org/10.1177/082585970502100403
  • Labore, N., Mawn, B., Dixon, J., & Andemariam, B. (2017). Exploring transition to self-management within the culture of sickle cell disease. Journal of Transcultural Nursing: Official Journal of the Transcultural Nursing Society, 28(1), 70–78. https://doi.org/10.1177/1043659615609404.
  • Laurence, B., George, D., & Woods, D. (2006). Association between elevated depressive symptoms and clinical disease severity in African-American adults with sickle cell disease. Journal of the National Medical Association, 98(3), 365–369.
  • Levenson, J. L., McClish, D. K., Dahman, B. A., Bovbjerg, V. E., de A Citero, V., Penberthy, L. T., Aisiku, I. P., Roberts, J. D., Roseff, S. D., & Smith, W. R. (2008). Depression and anxiety in adults with sickle cell disease: The PiSCES project. Psychosomatic Medicine, 70(2), 192–196. https://doi.org/10.1097/PSY.0b013e31815ff5c5
  • Leyro, T., Zvolensky, M., & Bernstein, A. (2010). Distress tolerance and psychopathological symptoms and disroders: A review of the empirical literature among adults. Psychological Bulletin, 136(4), 576–600. https://doi.org/10.1037/a0019712
  • Lusher, J., Elander, J., Bevan, D., Telfer, P., & Burton, B. (2006). Analgesic addiction and pseudoaddiction in painful chronic illness. The Clinical Journal of Pain, 22(3), 316–324. https://doi.org/10.1097/01.ajp.0000176360.94644.41
  • McCavit, T. (2012). Sickle cell disease. Pediatrics in Review, 33(5), 195–206. https://doi.org/10.1542/pir.33-5-195
  • McCracken, L. M., Matthews, A. K., Tang, T. S., & Cuba, S. L. (2001). A comparison of blacks and whites seeking treatment for chronic pain. The Clinical Journal of Pain, 17(3), 249–255. https://www.ncbi.nlm.nih.gov/pubmed/11587117 https://doi.org/10.1097/00002508-200109000-00011
  • Miller, W., Anton, H., & Townson, A. (2008). Measurement properties of the CESD scale among individuals with spinal cord injury. Spinal Cord, 46(4), 287–292. https://doi.org/10.1038/sj.sc.3102127
  • Nelson, S. C., & Hackman, H. W. (2013). Race matters: Perceptions of race and racism in sickle cell center. Pediatric Blood and Cancer, 60(3), 451-454. https://doi.org/10.1002/pbc.24361
  • Owens, M., Okunbor, J., Rainey, R., White, D., Mushatt, K., Yessick, L., Merlin, J., Turan., & Goodin, B. (2017). The impact of disease-specific internalized stigma on depressive symptoms, pain catastrophizing, pain interference, and alcohol use in people living with HIV and chronic pain. The Journal of Pain, 18(4), S45. https://doi.org/10.1016/j.jpain.2017.02.172
  • Pack-Mabien, A., Labbe, E., Herbert, D., & Haynes, J. Jr. (2001). Nurses' attitudes and practices in sickle cell pain management. Applied Nursing Research, 14(4), 187–192. https://doi.org/10.1053/apnr.2001.26783
  • Piel, F., Steinberg, M., & Rees, D. (2017). Sickle cell disease. The New England Journal of Medicine, 376(16), 1561–1573. https://doi.org/10.1056/NEJMra1510865
  • Quality, C. f. B. H. S. a (2015). Behavioral health trends in the United States: Results from the 2014 National Survey on Drug Use and Health. HHS Publication No. SMA 15-4927. https://www.samhsa.gov/data/sites/default/files/NSDUH-FRR1-2014/NSDUH-FRR1-2014.pdf
  • Ruta, N. S., & Ballas, S. K. (2016). The opioid drug epidemic and sickle cell disease: Guilt by Association. Pain Medicine (Malden, Mass.), 17(10), 1793–1798. https://doi.org/10.1093/pm/pnw074
  • Sanders-Phillips, K., & Harrell, S. (1996). Correlates of health promotion behaviors in low-income black women and latinas. American Journal of Health Promotion, 10(4), 308–317. https://doi.org/10.4278/0890-1171-10.4.308
  • Savage, S. R., Romero-Sandoval, A., Schatman, M., Wallace, M., Fanciullo, G., McCarberg, B., & Ware, M. (2016). Cannabis in pain treatment: Clinical and research considerations. The Journal of Pain: Official Journal of the American Pain Society, 17(6), 654–668. https://doi.org/10.1016/j.jpain.2016.02.007
  • Sehlo, M. G., & Kamfar, H. Z. (2015). Depression and quality of life in children with sickle cell disease: The effect of social support. BMC Psychiatry, 15(1), 78. https://doi.org/10.1186/s12888-015-0461-6
  • Shapiro, B. S., Benjamin, L. J., Payne, R., & Heidrich, G. (1997). Sickle cell-related pain: Perceptions of medical practitioners. Journal of Pain and Symptom Management, 14(3), 168–174. https://doi.org/10.1016/S0885-3924(97)00019-5
  • Simons, J., Gaher, R., Correia, C., Hansen, C., & Christopher, M. (2005). An affective-motivational model of marijuana and alcohol problems among college students. Psychology of Addictive Behaviors, 19(3), 326–334. https://doi.org/10.1037/0893-164X.19.3.326
  • Sullivan, M., Bishop, S., & Pivik, J. (1995). The pain catastrophizing scale: Development and validation. Psychological Assessment, 7(4), 524–532. https://doi.org/10.1037/1040-3590.7.4.524
  • Wakefield, E. O., Popp, J. M., Dale, L. P., Santanelli, J. P., Pantaleao, A., & Zempsky, W. T. (2017). Perceived racial bias and health-related stigma among youth with sickle cell disease. Journal of Developmental and Behavioral Pediatrics, 38(2), 129–134. https://doi.org/10.1097/DBP.0000000000000381
  • Wakefield, E. O., Pantaleao, A., Popp, J. M., Dale, L. P., Santanelli, J. P., Litt, M. D., & Zempsky, W. T. (2018). Describing perceived racial bias among youth with sickle cell disease. Journal of Pediatric Psychology, 43(7), 779–788. https://doi.org/10.1093/jpepsy/jsy015
  • Waugh, O. C., Byrne, D. G., & Nicholas, M. K. (2014). Internalized stigma in people living with chronic pain. Journal of Pain, 15(5), 550 e551-510. https://doi.org/10.1016/j.jpain.2014.02.001
  • Wilson, J., Vo, H., Matson, P., Adger, H., Barnett, G., & Fishman, M. (2017). Trait mindfulness and progression to injection use in youth with opioid addiction. Substance Use & Misuse, 52(11), 1486–1493. https://doi.org/10.1080/10826084.2017.1289225
  • Wolfson, J., Sheree, M., Schrager, S., Kipke, M., & Coates, T. (2009). Health care disparities in sickle cell disease: A population-based study of Los Angeles County. Blood, 114(22), 2480–2480. https://doi.org/10.1182/blood.V114.22.2480.2480
  • Young, D. (2018). Cognitive behavioral therapy group for reducing self-stigma for people with mental illness. Research on Social Work Practice, 28(7), 827–837. https://doi.org/10.1177/1049731516681849
  • Zempsky, W. (2009). Treatment of sickle cell pain: Fostering trust and justice. JAMA, 302(22), 2479–2480. https://doi.org/10.1001/jama.2009.1811

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.